HeXun Biosciences Co., Ltd.
6986StockTWO
60.60 ▲ +0.66%
12 juin 2026
6
HeXun Biosciences Co., Ltd.
60.60 ▲ +0.66%
12 juin 2026
6986StockTWO

01 / À propos

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.

Arberion
Loading market data